Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.

about

Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.

Item

http://www.wikidata.org/entity/Q50033931

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Observed frequency and challen ...... in a hereditary cancer clinic.

@en

Observed frequency and challen ...... in a hereditary cancer clinic.

@nl

type

Item

label

Observed frequency and challen ...... in a hereditary cancer clinic.

@en

Observed frequency and challen ...... in a hereditary cancer clinic.

@nl

prefLabel

Observed frequency and challen ...... in a hereditary cancer clinic.

@en

Observed frequency and challen ...... in a hereditary cancer clinic.

@nl

P1476

Observed frequency and challen ...... in a hereditary cancer clinic.

@en

P2093

Nisha Durand

http://www.w3.org/2001/XMLSchema#string

Paldeep Atwal

http://www.w3.org/2001/XMLSchema#string

Sarah Macklin

http://www.w3.org/2001/XMLSchema#string

Stephanie Hines

http://www.w3.org/2001/XMLSchema#string

P2860

Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Physicians' experiences with BRCA1/2 testing in community settings

Differential use of available genetic tests among primary care physicians in the United States: results of a national survey.

Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.

Public variant databases: liability?

P2888

gim.2017.207

P31

scholarly article

P356

10.1038/GIM.2017.207

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29215655

http://www.w3.org/2001/XMLSchema#string